Lv4
440 积分 2024-12-18 加入
Challenges and solutions for upstream processing of complex biologics
1个月前
已完结
Fed‐batch performance profiles for mAb production using different intensified N − 1 seed strategies are CHO cell‐line dependent
4个月前
已完结
An automated high inoculation density fed‐batch bioreactor, enabled through N‐1 perfusion, accommodates clonal diversity and doubles titers
4个月前
已完结
表达抗CD52单克隆抗体CHO细胞灌流培养工艺研究
5个月前
已关闭
Fed‐batch performance profiles for mAb production using different intensified N − 1 seed strategies are CHO cell‐line dependent
5个月前
已完结
Glycan Profiles of FDA-Approved Therapeutic Antibodies: Insights from Regulatory Submissions
5个月前
已完结
A high‐titer scalable Chinese hamster ovary transient expression platform for production of biotherapeutics
5个月前
已完结
A Review on the Current Methods of Chinese Hamster Ovary (CHO) Cells Cultivation for the Production of Therapeutic Protein
6个月前
已完结
Application of a curated genome-scale metabolic model of CHO DG44 to an industrial fed-batch process
6个月前
已完结
GMP implementation of a hybrid continuous manufacturing process for a recombinant non‐ mAb protein—A case study
8个月前
已完结
皖公网安备34019202002308
